6fusion Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • 6fusion's estimated annual revenue is currently $560k per year.(i)
  • 6fusion's estimated revenue per employee is $70,000

Employee Data

  • 6fusion has 8 Employees.(i)
  • 6fusion grew their employee count by -11% last year.

6fusion's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M42011%N/AN/A
#2
$0.6M8-11%N/AN/A
#3
$3.2M300%$7.5MN/A
#4
$3.4M30-9%N/AN/A
#5
$4.4M4121%$3.8MN/A
#6
$0.8M10-17%N/AN/A
#7
$3.6M3223%N/AN/A
#8
$7.2M5934%$51.3MN/A
#9
$1.3M1645%N/AN/A
#10
$4.3M3831%N/AN/A
Add Company

What Is 6fusion?

6fusion is standardizing the economic measurement of IT infrastructure, bringing together a global marketplace for buyers and sellers of IT infrastructure. 6fusion enables organizations to normalize IT infrastructure usage data to get a clear view of utilization rates, consumption patterns, and cost efficiencies. The Workload Allocation Cube (WAC) creates a standardized unit of measurement that turns IT infrastructure into a utility greatly simplifying consumption allocation reporting and chargeback while also creating an apples to apples comparison allowing users to make effective cloud allocation and infrastructure investment decisions.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$560k

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

6fusion News

2022-04-17 - Fusion Biopsy System Market 2022 | Covid19 Impact Analysis ...

Chapter 6: Fusion Biopsy System Production, Consumption, Export, and Import by Regions. Chapter 7: Fusion Biopsy System Market Status and...

2022-03-30 - Therapeutic antibodies against filoviruses including Ebola and Marburg

... 6: fusion loop, 7: Heptad repeat 1 (HR1), 8 and 9: Heptad repeat 2 (HR2); 9: stalk; and 10: and membrane-proximal external region (MPER)...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M80%N/A
#2
$0.6M8N/AN/A
#3
$1.1M80%N/A
#4
$0.8M8-73%N/A
#5
$0.6M8-20%N/A